Abstract

Background: Vascular calcification (VC) is a cardiovascular complication associated with a high mortality rate among patients with diseases such as atherosclerosis and chronic kidney disease. During VC, vascular smooth muscle cells (VSMCs) undergo an osteogenic switch and secrete a heterogeneous population of extracellular vesicles (EVs). Recent studies have shown involvement of EVs in the inflammation and oxidative stress observed in VC. We aimed to decipher the role and mechanism of action of macrophage-derived EVs in the propagation of inflammation and oxidative stress on VSMCs during VC. Methods: The macrophage murine cell line RAW 264.7 treated with lipopolysaccharide (LPS-EK) was used as a cellular model for inflammatory and oxidative stress. EVs secreted by these macrophages were collected by ultracentrifugation and characterized by transmission electron microscopy, cryo-electron microscopy, nanoparticle tracking analysis, and the analysis of acetylcholinesterase activity, as well as that of CD9 and CD81 protein expression by western blotting. These EVs were added to a murine VSMC cell line (MOVAS-1) under calcifying conditions (4 mM Pi—7 or 14 days) and calcification assessed by the o-cresolphthalein calcium assay. EV protein content was analyzed in a proteomic study and EV cytokine content assessed using an MSD multiplex immunoassay. Results: LPS-EK significantly decreased macrophage EV biogenesis. A 24-h treatment of VSMCs with these EVs induced both inflammatory and oxidative responses. LPS-EK-treated macrophage-derived EVs were enriched for pro-inflammatory cytokines and CAD, PAI-1, and Saa3 proteins, three molecules involved in inflammation, oxidative stress, and VC. Under calcifying conditions, these EVs significantly increase the calcification of VSMCs by increasing osteogenic markers and decreasing contractile marker expression. Conclusion: Our results show that EVs derived from LPS-EK–treated-macrophages are able to induce pro-inflammatory and pro-oxidative responses in surrounding cells, such as VSMCs, thus aggravating the VC process.

Highlights

  • Vascular calcification (VC) is a cardiovascular complication found among patients with diseases such as diabetes, atherosclerosis, and chronic kidney disease (CKD) (Lee et al, 2020)

  • 3.1.1 Lipopolysaccharide From Escherichia coli K12 Induces Inflammation in Macrophages In setting up our cellular model of inflammation, we first verified the effect of Lipopolysaccharide from Escherichia coli K12 (LPS-EK) on inflammation in RAW macrophages by measuring the mRNA levels of various pro-inflammatory cytokines (IL-6, IL-1β, TNF-α, and MIP-2), as well as that of the NLRP3 inflammasome marker, before and after treatment

  • Macrophages treated with LPS-EK showed significantly higher levels of these proinflammatory cytokines than untreated control cells (*p < 0.05 vs. CT, Supplementary Figure S2)

Read more

Summary

Introduction

Vascular calcification (VC) is a cardiovascular complication found among patients with diseases such as diabetes, atherosclerosis, and chronic kidney disease (CKD) (Lee et al, 2020). Recent studies have highlighted the role of extracellular vesicles (EVs) in VC (Hodroge et al, 2017; Mansour et al, 2020; Yaker et al, 2020; Qin et al, 2021) These membrane-bound vesicles, secreted by prokaryotic and eukaryotic cells (Woith et al, 2019), can be of various origins, depending on their mode of biogenesis. Several studies have showed macrophage-derived EVs to promote VC (New et al, 2013; Chen et al, 2016; Kawakami et al, 2020) Analysis of their content identified a subset of molecules involved in inflammation and oxidative stress, such as pro-inflammatory cytokines (Fitzgerald et al, 2018; Aiello et al, 2020) and oxidant machinery proteins (Bodega et al, 2019). During VC, vascular smooth muscle cells (VSMCs) undergo an osteogenic switch and secrete a heterogeneous population of extracellular vesicles (EVs).

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.